Target
E3 ubiquitin-protein ligase Mdm2
Ligand
BDBM50392241
Substrate
n/a
Meas. Tech.
ChEMBL_850546 (CHEMBL2157768)
Kd
14±n/a nM
Citation
 Zhan, CZhao, LWei, XWu, XChen, XYuan, WLu, WYPazgier, MLu, W An ultrahigh affinity d-peptide antagonist Of MDM2. J Med Chem 55:6237-41 (2012) [PubMed]  Article 
Target
Name:
E3 ubiquitin-protein ligase Mdm2
Synonyms:
Double minute 2 protein | Double minute 2 protein (HDM2) | E3 ubiquitin-protein ligase Mdm2 (p53-binding protein Mdm2) | Hdm2 | Human Double Minute 2 (HDM2) | MDM2 | MDM2-MDMX | MDM2_HUMAN | p53-Binding Protein MDM2 | p53-binding protein
Type:
Oncoprotein
Mol. Mass.:
55196.54
Organism:
Homo sapiens (Human)
Description:
Q00987
Residue:
491
Sequence:
MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP
  
Inhibitor
Name:
BDBM50392241
Synonyms:
CHEMBL2153361
Type:
Small organic molecule
Emp. Form.:
C72H105FN18O18
Mol. Mass.:
1529.7123
SMILES:
CC(C)C[C@@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](Cc1c[nH]c2cc(F)ccc12)NC(=O)[C@@H](C)NC(=O)[C@H](N)[C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCN=C(N)N)C(O)=O |r,wU:84.89,77.81,50.60,37.42,17.22,4.4,98.101,wD:82.86,62.77,45.46,26.34,8.13,90.93,(30.19,-17.41,;30.2,-15.86,;31.53,-15.1,;28.87,-15.09,;28.86,-13.55,;27.52,-12.78,;26.19,-13.56,;26.2,-15.1,;24.85,-12.79,;24.85,-11.25,;26.19,-10.46,;26.19,-8.92,;27.53,-8.17,;27.52,-6.6,;23.53,-13.56,;22.19,-12.78,;22.19,-11.24,;20.86,-13.56,;20.86,-15.1,;22.19,-15.86,;22.19,-17.4,;20.86,-18.17,;23.53,-18.18,;19.52,-12.79,;18.18,-13.56,;18.18,-15.1,;16.85,-12.79,;16.85,-11.25,;18.18,-10.47,;19.52,-11.25,;20.85,-10.46,;20.85,-8.92,;19.52,-8.17,;18.18,-8.94,;15.52,-13.56,;14.18,-12.79,;14.18,-11.25,;12.84,-13.56,;12.85,-15.1,;14.19,-15.86,;15.52,-15.1,;14.18,-17.41,;11.51,-12.79,;10.17,-13.56,;10.18,-15.1,;8.84,-12.79,;8.84,-11.25,;7.51,-13.56,;6.18,-12.79,;6.18,-11.25,;4.84,-13.56,;4.84,-15.1,;6.18,-15.87,;7.51,-15.1,;8.84,-15.88,;8.84,-17.42,;10.18,-18.18,;7.51,-18.18,;6.18,-17.41,;3.5,-12.79,;2.17,-13.56,;2.17,-15.1,;.84,-12.79,;.84,-11.25,;2.17,-10.48,;3.58,-11.1,;4.61,-9.96,;3.83,-8.62,;4.31,-7.15,;3.28,-6,;3.75,-4.54,;1.77,-6.33,;1.3,-7.8,;2.33,-8.95,;-.5,-13.56,;-1.84,-12.79,;-1.83,-11.25,;-3.17,-13.56,;-3.16,-15.11,;-4.5,-12.79,;-5.83,-13.56,;-5.83,-15.1,;-7.17,-12.79,;-8.5,-13.57,;-7.17,-11.25,;-8.5,-10.49,;-5.84,-10.49,;30.19,-12.79,;30.19,-11.25,;31.53,-13.56,;32.86,-12.78,;32.86,-11.24,;34.2,-10.46,;34.2,-8.92,;35.53,-11.23,;34.2,-13.55,;34.2,-15.09,;35.54,-12.77,;36.87,-13.54,;36.87,-15.1,;38.2,-15.85,;38.2,-17.39,;39.54,-18.17,;39.54,-19.71,;38.21,-20.48,;40.88,-20.48,;38.21,-12.78,;39.54,-13.55,;38.19,-11.24,)|
Structure:
Search PDB for entries with ligand similarity: